Back
Eagle Pharmaceuticals Quote, Financials, Valuation and Earnings
Invest in This AI Tech Innovator Doubling Revenue
Invest Now!
Sell
5
EGRX
Eagle Pharmaceuticals
Last Price:
2.12
Seasonality Move:
-3.84%
7 Day Trial
ALL ACCESS PASS
$
7
AI Tech Innovator Poised for Strategic Buyouts Invest Now
Learn MoreEagle Pharmaceuticals Price Quote
$2.12
+1.22 (+-40.28%)
(Updated: October 5, 2024 at 6:27 AM ET)
Eagle Pharmaceuticals Key Stats
Sell
5
Eagle Pharmaceuticals (EGRX)
is a Sell
Day range:
$0.75 - $2.00
52-week range:
$0.75 - $14.78
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
1.3M
Avg. volume:
310.6K
1-year change:
-93.78%
Market cap:
$11.7M
Revenue:
$0
EPS:
$0.91
How Much Does Eagle Pharmaceuticals Make?
-
How Much Are Eagle Pharmaceuticals's Sales Annually?
EGRX Revenues are $0 -
How Much Profit Does Eagle Pharmaceuticals's Make A Year?
EGRX net income is $0
Is Eagle Pharmaceuticals Growing As A Company?
-
What Is Eagle Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.13% -
What Is Eagle Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Eagle Pharmaceuticals Stock Price Performance
-
Did Eagle Pharmaceuticals Stock Go Up Last Month?
Eagle Pharmaceuticals share price went down by -80.48% last month -
Did EGRX's Share Price Rise Over The Last Year?
EGRX share price fell by -93.78% over the past 1 year
What Is Eagle Pharmaceuticals 52-Week High & Low?
-
What Is Eagle Pharmaceuticals’s 52-Week High Share Price?
Eagle Pharmaceuticals has traded as high as $14.78 over the past 52 weeks -
What Is Eagle Pharmaceuticals’s 52-Week Low Share Price?
Eagle Pharmaceuticals has traded as low as $0.75 over the past 52 weeks
Eagle Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Eagle Pharmaceuticals?
-
How Much Debt Does Eagle Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Eagle Pharmaceuticals Have?
Cash and short term investments quarterly total is $15.4M -
What Is Eagle Pharmaceuticals’s Book Value Per Share?
Book value per share is 19.25
Is Eagle Pharmaceuticals Cash Flow Positive?
-
What Is EGRX Cash Flow From Operations?
Cash flow from operations (TTM) is -$9.3M -
What Is Eagle Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $11.9M -
What Is Eagle Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$23.8M
Eagle Pharmaceuticals Return On Invested Capital
Data Unavailable
Eagle Pharmaceuticals Earnings Date & Stock Price
-
What Is Eagle Pharmaceuticals's Stock Price Today?
A single share of EGRX can be purchased today for 0.90 -
What Is Eagle Pharmaceuticals’s Stock Symbol?
Eagle Pharmaceuticals trades on the nasdaq under the ticker symbol: EGRX -
When Is Eagle Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Eagle Pharmaceuticals is scheduled on October 9, 2024 -
When Is EGRX's next ex-dividend date?
Eagle Pharmaceuticals's next ex-dividend date is October 6, 2024 -
How To Buy Eagle Pharmaceuticals Stock?
You can buy Eagle Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Eagle Pharmaceuticals Competitors
-
Who Are Eagle Pharmaceuticals's Competitors?
Below is a list of companies who compete with Eagle Pharmaceuticals or are related in some way:
Eagle Pharmaceuticals Dividend Yield
-
What Is EGRX Dividend Yield?
Eagle Pharmaceuticals’s dividend yield currently is 0% -
What Is Eagle Pharmaceuticals’s Payout Ratio?
Eagle Pharmaceuticals’s payout ratio is 0% -
When Did Eagle Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is October 6, 2024 -
What Is Eagle Pharmaceuticals’s Dividend Per Share?
Eagle Pharmaceuticals pays a dividend of $0.00 per share
Eagle Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 3.51% |
| Revenue: | -12.8% | 8.9% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 17.00 |
| Upside from Last Price: | 1789.1% |